stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / TECH / Free Cash Flow

Bio-Techne Corporation Free Cash Flow 2009–2025

Bio-Techne Corporation (TECH) annual free cash flow by fiscal year, computed from SEC filings. Compound growth +5.8%/yr over 16 years.

Fiscal yearFree Cash FlowChange (YoY)
FY 2025$256.55M+8.7%
FY 2024$236.10M+9.2%
FY 2023$216.15M-22.9%
FY 2022$280.36M-8.9%
FY 2021$307.86M+100.6%
FY 2020$153.47M-1.8%
FY 2019$156.21M+4.5%
FY 2018$149.43M+16.3%
FY 2017$128.54M+1.0%
FY 2016$127.26M+6.5%
FY 2015$119.45M-2.8%
FY 2014$122.94M+21.6%
FY 2013$101.11M-16.3%
FY 2012$120.73M-2.3%
FY 2011$123.56M+15.9%
FY 2010$106.62M+1.8%
FY 2009$104.77M

Source: Bio-Techne Corporation SEC filings — cash flow statement (10-K). Refreshed nightly.

See the full picture for Bio-Techne Corporation

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Bio-Techne Corporation — frequently asked questions

What is Bio-Techne Corporation's free cash flow?

Bio-Techne Corporation (TECH) reported free cash flow of $256.55M for fiscal year 2025, per its SEC filings.

How has Bio-Techne Corporation's free cash flow changed over time?

Between fiscal 2009 and 2025, TECH's free cash flow grew at roughly 5.8% per year (compound annual rate), from $104.77M to $256.55M.

Where does this data come from?

Figures are computed from Bio-Techne Corporation's official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.

More TECH financial history

Full TECH fundamentals page → · All 1,500+ companies →